The Heroin Prescribing Debate: Integrating Science and Politics
The Heroin Prescribing Debate: Integrating Science and Politics
复制标题
海洛因处方辩论：科学与政治的结合
作者：
C. Breen;L. Degenhardt;A. Roxburgh;R. Bruno;R. Jenkinson
对其他治疗没有反应的海洛因依赖者已接受海洛因和美沙酮联合治疗。在本次政策论坛上，
巴默
等人。
认为关于这种治疗方法优点的争论可以通过符合严格科学标准的临床试验来充分了解。由于与依赖使用者群体合作的复杂性以及与这种潜在治疗相关的社会和个人风险，因此必须进行一系列具有不同设计和对照组的连锁试验，并且还必须监测社会影响。海洛因永远是第二选择，而不是首选治疗方法，如果试验表明它有任何价值，政治结果将是医疗化，而不是合法化。
People dependent on heroin who do not respond to other treatments have been treated by a combination of heroin and methadone. In this Policy Forum,
Bammer
et al.
argue that the debate about the merits of this treatment could be substantially informed by clinical trials that meet rigorous scientific standards. Because of the complexities of working with the dependent user population and the social and individual risks associated with this potential treatment, a series of interlocking trials with various designs and control groups are essential, and social impacts must also be monitored. Heroin will always be a second- rather than first-choice treatment, and if trials show that it has any value, the political outcome will be medicalization, not legalization.